You have 9 free searches left this month | for more free features.

City

Lincoln (2)

Condition

Heparin Induced Thrombocytopenia (1)

Heparin-induced Thrombocytopenia (1)

Safety and Tolerability in Healthy Volunteers (1)

Thrombocytopenia, Immune (1)

Overall Status

Completed (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Veralox Therapeutics (3)

Collaborator

Celerion (1)

Intervention

vlx-1005 (3)

placebo (2)

argatroban (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

vlx-1005

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia Trial (VLX-1005, Placebo)

Not yet recruiting

Thrombocytopenia, Immune
Heparin Induced Thrombocytopenia

VLX-1005
Placebo

(no location specified)

Mar 24, 2023

Heparin-induced Thrombocytopenia Trial in Lincoln (VLX-1005, Argatroban)

Completed

Heparin-induced Thrombocytopenia

VLX-1005
Argatroban

Lincoln, Nebraska

Celerion, Inc.

Jan 10, 2023

Safety and Tolerability in Healthy Volunteers Trial in Lincoln (VLX-1005, Placebo)

Completed

Safety and Tolerability in Healthy Volunteers

VLX-1005
Placebo

Lincoln, Nebraska

Celerion, Inc.

Apr 26, 2022